funder-graph › Recipients
Who funds University of Texas Md Anderson Cancer Center
EIN 76-6001118
University of Texas Md Anderson Cancer Center (EIN 76-6001118) was named as a grant recipient by 3 funders in 7 grants paid totaling $553,217 in tax years 2018–2024, as reported on the funders' Forms 990-PF and 990 Schedule I. Each edge was resolved to this EIN at the match tier shown. Dataset version 2026.09.0, built 2026-09-03.
Grants received
$553,217
7 grants paid
Funders
3
distinct grantmakers
Tax years
2018–2024
as reported by funders
Funders
| Funder | State | Match | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Pediatric Cancer Research Foundation 95-3772528 | CA | A | 5 | $429,217 | 2023 |
| Doctor Marnie Rose Foundation Inc 45-2774942 | TX | A | 1 | $120,000 | 2024 |
| Moore Impact Inc 84-4714243 | CO | A | 1 | $4,000 | 2024 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Grants
The 7 most recent grants naming this organization.
| Tax year | Funder | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|---|
| 2024 | Doctor Marnie Rose Foundation Inc | The University of Texas Md Anderson Cancer Center Houston, TX | A | $120,000 | paid | Cancer research | 202542839349300204 |
| 2024 | Moore Impact Inc | The University of Texas Md Anderson Cancer Center Houston, TX | A | $4,000 | paid | PROGRAM SUPPORT/PROJECT SUPPORT | 202512829349300241 |
| 2023 | Pediatric Cancer Research Foundation | Md Anderson Houston, TX | A | $91,717 | paid | COMBINING A NOVEL DENDRITIC CELL VACCINE WITH CHECKPOINT BLOCKADE FOR OSTEOSARCOMA THERAPY | 202402729349300305 |
| 2022 | Pediatric Cancer Research Foundation | University of Texas Md Anderson Cancer Center Houston, TX | A | $125,000 | paid | COMBINING A NOVEL DENDRITIC CELL VACCINE WITH CHECKPOINT BLOCKADE FOR OSTEOSARCOMA THERAPY | 202322719349302127 |
| 2021 | Pediatric Cancer Research Foundation | University of Texas Md Anderson Cancer Center Houston, TX | A | $125,000 | paid | BASIC RESEARCH SCIENCE GRANT COMBINING A NOVEL DENDRITIC CELL VACCINE WITH CHECKPOINT BLOCKADE FOR OSTEOSARCOMA THERAPY | 202202729349301750 |
| 2020 | Pediatric Cancer Research Foundation | University of Texas Md Anderson Cancer Center Houston, TX | A | $87,500 | paid | TRANSLATIONAL SCIENCE AWARD FOR NEUROBLASTOMA RELAPSE | 202132789349300548 |
| 2018 | Pediatric Cancer Research Foundation | University of Texas Md Anderson Cancer Center Houston, TX | A | $0 + $75,000 non-cash | paid | TRANSLATIONAL SCIENCE AWARD FOR NEUROBLASTOMA RELAPSE | 201913019349301186 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are inferred and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF and Form 990 Schedule I e-file XML filed by the funders shown; this organization's identity from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The rows as Parquet: manifest.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.